Massive 5,000-Patient study tracks heart failure device
Disease control
Ongoing
This study is collecting real-world information from 5,000 people with heart failure who have already received the Barostim device. The goal is to understand the long-term safety and benefits of the device in everyday use. Researchers will track patients' health for up to three y…
Sponsor: CVRx, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC